ATE414082T1 - Antibiotische tetrahydro-b-carbolinderivative - Google Patents

Antibiotische tetrahydro-b-carbolinderivative

Info

Publication number
ATE414082T1
ATE414082T1 AT04750953T AT04750953T ATE414082T1 AT E414082 T1 ATE414082 T1 AT E414082T1 AT 04750953 T AT04750953 T AT 04750953T AT 04750953 T AT04750953 T AT 04750953T AT E414082 T1 ATE414082 T1 AT E414082T1
Authority
AT
Austria
Prior art keywords
carboline derivatives
tetrahydro
ppat
structural formula
bacteria
Prior art date
Application number
AT04750953T
Other languages
English (en)
Inventor
Timothy Opperman
Anthony Arvanites
Julia Pinto
Yibin Xiang
Syed Ali
Bolin Geng
Mark Ashwell
Alan Kaplan
Original Assignee
Oscient Pharmaceuticals
Arqule Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oscient Pharmaceuticals, Arqule Inc filed Critical Oscient Pharmaceuticals
Application granted granted Critical
Publication of ATE414082T1 publication Critical patent/ATE414082T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Maintenance And Management Of Digital Transmission (AREA)
AT04750953T 2003-04-29 2004-04-29 Antibiotische tetrahydro-b-carbolinderivative ATE414082T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46653703P 2003-04-29 2003-04-29

Publications (1)

Publication Number Publication Date
ATE414082T1 true ATE414082T1 (de) 2008-11-15

Family

ID=33418394

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04750953T ATE414082T1 (de) 2003-04-29 2004-04-29 Antibiotische tetrahydro-b-carbolinderivative

Country Status (8)

Country Link
US (1) US20060273819A1 (de)
EP (1) EP1628977B1 (de)
JP (1) JP2006525347A (de)
AT (1) ATE414082T1 (de)
AU (1) AU2004234405A1 (de)
CA (1) CA2524125A1 (de)
DE (1) DE602004017714D1 (de)
WO (1) WO2004096802A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8571070B2 (en) * 2005-12-02 2013-10-29 Broadcom Corporation Method and system for speed negotiation for twisted pair links in fibre channel sytems
WO2009073534A2 (en) 2007-11-30 2009-06-11 Maxthera Inc. Bicyclic ppat inhibitors as antibacterial agents
AU2008350293A1 (en) * 2007-11-30 2009-08-20 Biota Scientific Management Pty Ltd Antibiotic tetrahydro-beta-carboline derivatives
KR101331123B1 (ko) 2008-07-15 2013-11-19 엘에스아이 코포레이션 Ｓａｎ내의 컴포넌트들의 인증동안 프로토콜 특정 에러들을 주입하기 위한 시스템
US9319348B2 (en) * 2011-05-24 2016-04-19 Cisco Technology, Inc. Octal serial gigabit media-independent interface
KR20150000882A (ko) 2012-04-05 2015-01-05 씨에이치디아이 파운데이션, 인코포레이티드 키뉴레닌-3-모노산소첨가효소 억제제들, 약학 조성물들 및 이의 사용 방법
EP2775652B1 (de) * 2013-03-07 2018-08-22 Viavi Solutions Deutschland GmbH Bitfehlermusteranalysegerät und Verfahren
EP3049077A4 (de) * 2013-09-26 2017-02-15 CHDI Foundation, Inc. Kynurenin-3-monooxygenase-hemmer, pharmazeutische zusammensetzungen und verfahren zur verwendung davon
ES2754473T3 (es) 2013-09-26 2020-04-17 Chdi Foundation Inc Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas, y método de uso de los mismos
US9531625B2 (en) * 2015-01-28 2016-12-27 Ciena Corporation System and method for providing redundant network connections
CN119462646A (zh) * 2024-11-07 2025-02-18 江苏科技大学 一种取代的四氢-β-咔啉衍生物、其合成方法及其用途
CN119528904B (zh) * 2025-01-21 2025-04-25 成都湃来生物科技有限公司 具有抗菌活性的吲哚衍生物、其制备方法、其用途及其制成的药物组合物和医疗器械

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1055203A (en) * 1964-09-16 1967-01-18 Ici Ltd -ß-carboline derivatives, a process for their manufacture, and compositions containing them
US4283536A (en) * 1977-12-29 1981-08-11 University Of Vermont Preparation of vincadifformine and related derivatives
FR2619111B1 (fr) * 1987-08-07 1991-01-11 Synthelabo Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
CO5370679A1 (es) * 1999-06-01 2004-02-27 Smithkline Beecham Corp Inhibidores fab 1
FR2796644B1 (fr) * 1999-07-23 2001-09-07 Adir Nouveaux derives de beta-carboline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1286994A1 (de) * 2000-05-15 2003-03-05 Darwin Discovery Limited Hydroxamsäure- und carbonsäure-derivate mit mmp und tnf hemmender wirkung
US6720330B2 (en) * 2000-11-17 2004-04-13 Pfizer Inc. Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
US6987115B2 (en) * 2000-12-08 2006-01-17 Smithkline Beecham Corporation Antibacterial compounds
ES2272695T3 (es) * 2001-02-12 2007-05-01 Lilly Icos Llc Derivados de carbolina.
ES2248412T3 (es) * 2001-02-12 2006-03-16 Lilly Icos Llc Derivados de carbolina.
JPWO2003035653A1 (ja) * 2001-10-26 2005-02-10 日本曹達株式会社 ピリドチエノピリミジン化合物およびその塩
TWI329111B (en) * 2002-05-24 2010-08-21 X Ceptor Therapeutics Inc Azepinoindole and pyridoindole derivatives as pharmaceutical agents

Also Published As

Publication number Publication date
AU2004234405A1 (en) 2004-11-11
WO2004096802A9 (en) 2005-01-20
JP2006525347A (ja) 2006-11-09
EP1628977B1 (de) 2008-11-12
DE602004017714D1 (de) 2008-12-24
WO2004096802A3 (en) 2005-05-12
WO2004096802A2 (en) 2004-11-11
US20060273819A1 (en) 2006-12-07
EP1628977A2 (de) 2006-03-01
CA2524125A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
WO2009073545A3 (en) Tetrahydro-isoquinoline ppat inhibitors as antibacterial agents
DE60309701D1 (de) 2-ureido-6-heteroaryl-3h-benzoimidazol-4-carbonsäurederivate und verwandte verbindungen als gyrase und/oder topoisomerase iv inhibitoren zur behandlung von bakteriellen infektionen
MXPA05008126A (es) Inhibidores de girasa y uso de los mismos.
DE69433901D1 (de) Verbindungen und pharmazeutische zusammensetzungen zur behandlung und prophylaxe bakterieller infektionen
NO20074703L (no) Antibakterielle piperidinderivater
NO20080338L (no) Forbindelser for behandling av multilegemiddelresistente bakterielle infeksjoner
IL189017A0 (en) 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-effective agents
WO2007014372A3 (en) Compositions and methods for treating bacteria
MXPA05009352A (es) Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas.
ATE414082T1 (de) Antibiotische tetrahydro-b-carbolinderivative
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
NZ510369A (en) Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
TW200734344A (en) Antibacterial agents
WO2009073534A3 (en) Bicyclic ppat inhibitors as antibacterial agents
MX2022014485A (es) Antibioticos macrociclicos de amplio espectro.
WO2004096822A3 (en) Pyridyl substituted ketolide antibiotics
NO20055893L (no) Nye linkomycinderivativer med antimikrobiell aktivitet
WO2009102377A3 (en) Antibiotic tetrahydro-beta-carboline derivatives
WO2006120563A3 (en) Antibacterial agents
BRPI0417421A (pt) composto, composição farmacêutica, método para tratamento ou controle de infecções bacterianas, processo para preparação do composto e produto manufaturado
EA200901059A1 (ru) Макролиды на основе эритромицина
NO20080314L (no) Bicykliske 6-alkyliden-penem B-laktamase inhibitorer og B-laktam antibiotisk kombinasjon: et bred spektret antibiotika
DE60137459D1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
ATE509018T1 (de) Als antimikrobielle mittel geeignete bisindolpyrrole
WO2005027856A3 (en) Inhibitors of anthrax lethal factor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties